Journey Medical CorporationDERMNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P23
Within normal range
vs 2Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -152.97% |
| Q2 2025 | 66.74% |
| Q1 2025 | -227.28% |
| Q4 2024 | 292.31% |
| Q3 2024 | 77.65% |
| Q2 2024 | -3.13% |
| Q1 2024 | 56.09% |
| Q4 2023 | -160.96% |
| Q3 2023 | 372.34% |
| Q2 2023 | 166.64% |
| Q1 2023 | 75.01% |
| Q4 2022 | -227.33% |
| Q3 2022 | -120.67% |
| Q2 2022 | 82.74% |
| Q1 2022 | -333.86% |
| Q4 2021 | -159.48% |
| Q3 2021 | 77.17% |
| Q2 2021 | -646.51% |
| Q1 2021 | -71.96% |
| Q4 2020 | 553.22% |
| Q3 2020 | -286.42% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q3 2019 | 90.08% |
| Q2 2019 | 9.42% |
| Q1 2019 | 12.36% |
| Q4 2018 | 41.91% |
| Q3 2018 | -470.65% |
| Q2 2018 | 56.91% |
| Q1 2018 | -72.04% |
| Q4 2017 | 1.54% |
| Q3 2017 | -116.59% |
| Q2 2017 | 40.36% |
| Q1 2017 | -64351.28% |
| Q4 2016 | 100.18% |
| Q3 2016 | 23.80% |
| Q2 2016 | -6.00% |
| Q1 2016 | -80.67% |
| Q4 2015 | 3.01% |
| Q3 2015 | -5.24% |